RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.220
+0.040 (3.39%)
At close: Nov 11, 2026, 4:00 PM EST
1.250
+0.030 (2.46%)
Pre-market: Nov 12, 2026, 7:18 AM EST
RenovoRx Revenue
RenovoRx had revenue of $1.07M in the quarter ending September 30, 2026, with 300.75% growth. This brings the company's total for the last twelve months to $2.78M, up 199.14% year-over-year. In the year 2025, RenovoRx had annual revenue of $1.12M with 2,511.63% growth. That makes RenovoRx the 41,656th largest company in the world by revenue and 5,613th in the United States.
Revenue (ttm)
$2.78M
Revenue Growth
+199.14%
P/S Ratio
19.83
Revenue / Employee
$163,294
Employees
17
Market Cap
55.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12M | 1.08M | 2,511.63% |
| Dec 31, 2024 | 43.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
RNXT News
- 18 hours ago - RenovoRx Transcript: Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum - Transcripts
- 1 day ago - RenovoRx Slides: Corporate presentation - Filings
- 6 days ago - RenovoRx reports Q3 EPS (7c), consensus (5c) - TheFly
- 6 days ago - RenovoRx backs FY26 revenue view $3.75M-$4.25M, consensus $3.87M - TheFly
- 6 days ago - RenovoRx Earnings Call Transcript: Q3 2026 - Transcripts
- 6 days ago - RenovoRx Earnings release: Q3 2026 - Filings
- 6 days ago - RenovoRx Quarterly report: Q3 2026 - Filings
- 6 days ago - RenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million - GlobeNewsWire